Vaxcyte
Bookmark
ShareVaxcyte is a company. It is in San Carlos, the United States and it has a male CEO called Grant E. Pickering. It was founded in 2013 and is part of the Health Care sector, specifically in the Biotechnology industry.
Key facts
- city: San Carlos
- state: CA
- country: United States
- employees: 89 people
- revenues: Try Pro to see estimate
- sector: Health Care
- industry: Biotechnology
- foundation year: 2013
- CEO: Grant E. Pickering
- CEO gender: male
- ESG score: Try Pro to see estimate
See more facts
Extract data
Download datasets about Vaxcyte:
Stocks from Vaxcyte:
Vaxcyte is one of the companies in Grant E. Pickering, companies in the United States, companies in Biotechnology, companies in Health Care and 3,584,319 companies in our database.
Talking Points
- Homepage - Vaxcyte
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
